Nanette Cocero - 23 Jun 2025 Form 4 Insider Report for HilleVax, Inc. (HLVX)

Role
Director
Signature
/s/ Paul Bavier, Attorney-in-Fact for Nanette Cocero
Issuer symbol
HLVX
Transactions as of
23 Jun 2025
Net transactions value
$0
Form type
4
Filing time
25 Jun 2025, 16:19:24 UTC
Previous filing
30 Apr 2025
Next filing
17 Sep 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Cocero Nanette Director C/O HILLEVAX, INC.,, 321 HARRISON AVE, SUITE 500, BOSTON /s/ Paul Bavier, Attorney-in-Fact for Nanette Cocero 25 Jun 2025 0001976937

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HLVX Common Stock Award $0 +17,199 $0.000000 17,199 23 Jun 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Restricted Stock Units ("RSUs") were granted on June 23, 2025 pursuant to the Registrant's Non-Employee Director Compensation Program. 100% of the total number of RSUs granted shall vest on the first to occur of (i) the first anniversary of the date of grant or (ii) a Change in Control (as defined in the Registrant's 2022 Incentive Award Plan), in each case, subject to the non-employee director continuing in service on the Registrant's board of directors through such vesting date.